Covid cases: Health ministry asks states to ensure availability of oxygen, isolation beds, ventilators
New Delhi: All states have been instructed to ensure availability of oxygen, isolation beds, ventilators and essential medicines in view of rising cases of Covid, official sources said on Wednesday.
A series of technical review meetings were held on June 2 and 3 under the chairpersonship of Director General of Health Services (DGHS) Dr Sunita Sharma.
The meeting was held with representatives of Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and central government hospitals in Delhi and with representatives from all states and Union territories to evaluate the current Covid situation and preparedness measures.
According to the sources, state and district surveillance units under IDSP are closely monitoring Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI).
"Testing is recommended for all admitted SARI cases and 5 per cent of ILI cases as per guidelines and positive SARI samples are sent for Whole Genome Sequencing through the ICMR VRDL network," an official source said.
As of June 4, India reported 4,302 active cases, with an increase of 864 cases in the past 24 hours.
The official sources said most cases are mild and managed under home care.
Since January 1, 44 deaths have been reported, primarily among individuals with pre-existing illnesses, they said.
"States have been instructed to ensure availability of oxygen, isolation beds, ventilators, and essential medicines," the source said.
A mock drill assessing oxygen supply systems (PSA plants, LMO tanks, MGPS lines) was conducted on June 2. Facility-level preparedness mock drills are planned for Wednesday and Thursday.
The official sources advised people to practise hand hygiene, cough etiquette, and avoid crowded places when unwell and that individuals with acute respiratory illness should self-monitor and seek medical care if symptoms worsen.
Trusted sources such as health ministry's website and PIB releases should be followed to avoid misinformation and rumours, they said.
"Union health ministry continues to closely monitor the situation and remains committed to ensuring public health safety through timely interventions and effective communication," the source asserted. PTI>
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
38 minutes ago
- New Indian Express
35-year-old man with comorbidities dies ten days after testing positive for COVID-19
VILLUPURAM: A 35-year-old man passed away ten days after testing positive for COVID-19 at the Villupuram government medical college hospital on June 6. The deceased, identified as Thiagarajan, a native of Perapperi village near Tindivanam, had been working as a construction contractor in Hyderabad. He allegedly contracted the virus while at work in Hyderabad ten days ago. Following the onset of fever and other COVID-related symptoms, he returned to his native village in Tindivanam, a week ago. Initially admitted to the Tindivanam government hospital, Thiagarajan was later referred to the Villupuram government medical college hospital for advanced treatment after his condition worsened early on June 6. Despite intensive medical efforts, he passed away due to cardiac failure, medical sources said. The deceased was diabetic, suffered from hypertension, cardiac issues and was under medication for Tuberculosis. Further, sources stated that his health deteriorated rapidly after his return from Hyderabad, leading to his eventual demise. Speaking to TNIE, Villupuram Deputy Director Health Services Dr Senthil Kumar said, "The patient tested positive for COVID in Hyderabad. However, he tested negative on Friday morning, but he died due to comorbidities. Six members who were in contact with him were isolated. People in the village have been asked to follow COVID-19 safety guidelines."
India Today
an hour ago
- India Today
New coronavirus in China shows pandemic-like threat, scientists warn
A group of mysterious bat viruses might be just one tiny mutation away from becoming a serious problem for humans, warn US researchers in a new study published in the peer-reviewed journal Nature viruses belong to the same family as MERS-CoV, a dangerous coronavirus that emerged in 2012 and causes severe respiratory a death rate of around 34%, MERS-CoV has already shown the world what these viruses are capable Now, scientists from Washington State University, Caltech, and the University of North Carolina have turned their focus to a lesser-known subgroup called these, one subgroup in particular, called the HKU5 viruses, is raising red flags."HKU5 viruses haven't been studied much, but our research shows they have the machinery to infect cells. In fact, they might be only a single step away from being able to infect humans,' said Dr. Michael Letko, a virologist and lead author of the IS THIS WORRYING?Like the SARS-CoV-2 virus that causes Covid-19, these bat viruses use a spike protein to latch onto cells and infect them. With a death rate of around 34%, MERS-CoV has already shown the world what these viruses are capable of. () advertisementThis study showed that HKU5 viruses can bind to a receptor called ACE2, the same one used by Covid-19, but currently only in bats, not that line is thinner than it just a small genetic tweak, these viruses could potentially start binding to human cells. In fact, some versions have already been spotted infecting minks in China, a sign that they can jump across if that mutation happens in just the right way, the next big spillover could be on the horizon."These viruses are very close relatives of MERS. That alone should make us pay attention," Letko said in a take the research a step further, scientists also used AI, specifically a tool called AlphaFold 3, to simulate how the spike protein would interact with ACE2 receptors. This study showed that HKU5 viruses can bind to a receptor called ACE2, the same one used by Covid-19, but currently only in bats, not humans.() This software predicted virus behaviour in minutes, a process that would usually take months of lab work. The AI's findings closely matched results from traditional lab researchers had earlier shared findings of the new bat coronavirus, HKU5-CoV-2 in study led by virologist Shi Zhengli, who is also known as the 'batwoman".Zhengli found that in lab experiments, HKU5-CoV-2 infected human cells with high ACE2 levels in test tubes and in models of human intestines and researchers also identified monoclonal antibodies and antiviral drugs that target the bat DOES THIS STUDY MATTER?The study's findings matter because, as we've learned from Covid-19, viruses don't need a passport to go global. If we ignore the warning signs, we risk another pandemic blindsiding an eye on viruses like HKU5 gives scientists a head start in developing vaccines, treatments, and public health strategies, before it's too Dr. Letko put it, there's no need to panic, but there is every reason to prepare.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
NB.1.8.1 Covid-19 variant makes up 10% cases globally: Should you worry?
Just when many believed Covid-19 was in the rear-view mirror, a new variant has quietly gained ground. NB.1.8.1, first detected in China in January 2025, now accounts for one in ten Covid-19 cases globally—up from just one in forty a month ago. It has spread across twenty-two countries so far. What is NB.1.8.1 variant? According to the World Health Organization, NB.1.8.1 is among several fast-evolving Omicron-lineage variants. From January to May 2025, global dominance shifted from XEC to LP.8.1, with NB.1.8.1 now surging rapidly. The WHO has classified NB.1.8.1 as a Variant Under Monitoring due to its rise in prevalence and potential public health implications. Officials stress that while vigilance is crucial, there is no cause for alarm. Vaccination remains the best protection against severe illness and death. How NB.1.8.1 behaves and how severe it really is NB.1.8.1 is a sublineage of the Omicron JN.1 family. It carries similar characteristics—high transmissibility, but mostly mild to moderate illness. It also includes new mutations on the spike protein, which may enhance its ability to spread and evade immunity. So far, there is no evidence to suggest NB.1.8.1 causes more severe disease, hospitalisations or death compared to previous variants. NB.1.8.1 symptoms: What to watch for Common symptoms include: Dry, persistent cough Runny or blocked nose Fatigue and general body aches Sore throat Fever or chills Headache or hoarseness in some cases Many report being able to go about daily activities but feel unusually tired and sluggish. Are vaccines still effective against NB.1.8.1? Updated vaccines, including the latest Omicron-targeted boosters, are designed to protect against the JN.1 family. While they may not prevent all infections, they continue to reduce the risk of hospitalisation and severe outcomes. Expert guidance includes: If you are over sixty, have chronic health conditions or are immunocompromised, get a booster if it has been more than six months since your last dose If you are healthy and under sixty, no new dose is required at present Use masks in public transport and crowded indoor spaces How to manage NB.1.8.1 symptoms at home In most cases, NB.1.8.1 does not require hospitalisation. Here is what helps: Rest and stay well hydrated Use paracetamol or other over-the-counter medications for fever or aches Recovery generally takes five to seven days If you are elderly or immunocompromised, speak to your doctor early. Antiviral medication is most effective within five days of the onset of symptoms. Warning signs: When to seek emergency help Seek urgent medical care if you experience any of the following: Difficulty breathing Chest pain or tightness Confusion or trouble staying awake Severe dizziness or fainting Do not panic, but stay informed Experts believe NB.1.8.1 will follow a familiar seasonal pattern seen with earlier variants—periodic surges during winter and summer months. Most infections remain mild. Vaccines continue to work. Keep an eye on symptoms, isolate if unwell, and consult your doctor when in doubt.
